I supported the creation of a pathway for biosimilars, and for empowering FDA with the authority and resources to ensure that biosimilars are safely available here in the U.S. for the patients that need them the most.
Pitts discusses his support for biosimilar approval pathways to benefit patients.
Share
More from Joe Pitts
It is unfortunate that we have a Congress of the United States, the majority parties that want to just tear down this law.
Today's hearing is especially timely as we learned startling news over the summer, confirming our worst fears, that the some of the most significant health insurers--UnitedHealth, Aetna, Humana--are opting out of Obamacare's health…
Today's Health Subcommittee hearing will examine the Federal mental health parity laws and regulations.
Today's hearing is an important discussion that will examine the areas where we can improve our national trauma system.
Other voices in this conversation
